SLXN
Biomotion Sciences Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.10M
P/E Ratio
—
EPS
$-5.97
Beta
-0.29
52W High
$22.36
52W Low
$0.23
50-Day MA
$0.93
200-Day MA
$2.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biomotion Sciences Ordinary Shares
Biomotion Sciences (SLXN) is a pioneering biotechnology company focused on regenerative medicine, committed to developing innovative therapies for severe medical conditions with substantial unmet needs. The company boasts a strong pipeline of product candidates aimed at transforming patient care and outcomes. With strategic partnerships enhancing its research and development efforts, Biomotion Sciences is strategically positioned to make significant contributions to the biotechnology sector, making it an attractive investment opportunity for institutional investors interested in advanced therapeutic solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-12.72M |
| Operating Margin | 0.00% |
| Return on Equity | -897.00% |
| Return on Assets | -123.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.83 |
| Price-to-Book | 7.10 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.19M |
| Float | $4.16M |
| % Insiders | 8.05% |
| % Institutions | 4.55% |
Historical Volatility
HV 10-Day
112.59%
HV 20-Day
109.50%
HV 30-Day
93.72%
HV 60-Day
99.76%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($6.00 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026